GILLIAN MELIKIAN: Open Payments
NPI 1902659584 · JOHNSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,393 in 112 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $751 · 2025 $3,393
Food & beverage: $3,328Education: $65
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $758 |
| ABBVIE INC. | 28 | $596 |
| Arcutis Biotherapeutics, Inc. | 8 | $409 |
| UCB, Inc. | 11 | $400 |
| LEO Pharma Inc. | 10 | $344 |
| E.R. Squibb & Sons, L.L.C. | 11 | $235 |
| Organon LLC | 5 | $128 |
| Amgen Inc. | 4 | $115 |
| Lilly USA, LLC | 6 | $111 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
Products named: TREMFYA, SKYRIZI, Zoryve, Bimzelx, ADBRY, Sotyktu, RINVOQ, VTAMA.
Industry payments across RI — which companies pay providers there.
